IBL HealthCare Limited (PSX:IBLHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
57.36
-0.51 (-0.88%)
At close: Nov 28, 2025

IBL HealthCare Ratios and Metrics

Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Nov '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
5,6515,3632,6482,3243,3746,011
Upgrade
Market Cap Growth
74.42%102.52%13.95%-31.13%-43.86%43.49%
Upgrade
Enterprise Value
6,0845,7232,7722,5763,5706,294
Upgrade
Last Close Price
57.3654.4326.8823.5933.5459.16
Upgrade
PE Ratio
25.9425.74350.527.5211.1420.00
Upgrade
PS Ratio
1.291.240.740.580.922.00
Upgrade
PB Ratio
2.362.311.251.101.813.72
Upgrade
P/TBV Ratio
2.362.311.251.111.823.75
Upgrade
P/FCF Ratio
--4.6895.4960.7492.35
Upgrade
P/OCF Ratio
--4.6685.5459.3685.90
Upgrade
EV/Sales Ratio
1.391.320.770.640.982.10
Upgrade
EV/EBITDA Ratio
13.1912.7817.724.206.2015.29
Upgrade
EV/EBIT Ratio
13.4212.8718.084.236.2615.47
Upgrade
EV/FCF Ratio
-75.44-4.89105.8764.2696.70
Upgrade
Debt / Equity Ratio
0.190.070.010.140.140.16
Upgrade
Debt / EBITDA Ratio
0.990.350.140.480.460.62
Upgrade
Debt / FCF Ratio
--0.0412.234.813.97
Upgrade
Asset Turnover
1.111.181.051.241.361.28
Upgrade
Inventory Turnover
2.622.652.532.492.852.91
Upgrade
Quick Ratio
1.271.191.441.031.151.20
Upgrade
Current Ratio
2.002.022.242.052.202.27
Upgrade
Return on Equity (ROE)
9.55%9.39%0.36%15.56%17.42%19.79%
Upgrade
Return on Assets (ROA)
7.22%7.58%2.79%11.76%13.27%10.82%
Upgrade
Return on Capital (ROIC)
10.41%12.03%4.22%16.80%17.82%14.64%
Upgrade
Return on Capital Employed (ROCE)
18.80%19.00%7.30%28.90%30.50%24.90%
Upgrade
Earnings Yield
3.86%3.89%0.29%13.30%8.97%5.00%
Upgrade
FCF Yield
-1.43%-5.20%21.39%1.05%1.65%1.08%
Upgrade
Dividend Yield
----1.96%0.93%
Upgrade
Payout Ratio
0.01%0.08%0.56%20.11%17.05%34.42%
Upgrade
Buyback Yield / Dilution
-0.18%--0.00%-0.00%0.00%
Upgrade
Total Shareholder Return
-0.18%---1.96%0.93%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.